Invention Application
- Patent Title: COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
-
Application No.: US14994827Application Date: 2016-01-13
-
Publication No.: US20160120866A1Publication Date: 2016-05-05
- Inventor: Shenlin Huang , Xianming Jin , Zuosheng Liu , Daniel Poon , John Tellew , Yongqin Wan , Xing Wang , Yongping Xie
- Applicant: Novartis AG
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K31/4184 ; A61K9/00
Abstract:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
Public/Granted literature
- US09593100B2 Compounds and compositions as protein kinase inhibitors Public/Granted day:2017-03-14
Information query
IPC分类:
